Edition:
United Kingdom

People: Oxford BioMedica PLC (OXB.L)

OXB.L on London Stock Exchange

730.00GBp
18 Jun 2019
Change (% chg)

-- (--)
Prev Close
730.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
73,436
52-wk High
1,064.38
52-wk Low
575.32

Paynter, Stuart 

Mr. Stuart Paynter is the Chief Financial Officer, Director of the Company. Stuart is currently Finance Director, Head of Business Partnering at De La Rue Plc where he has led the finance business partnering function for the global company, with responsibility for managing finance interaction with all stakeholders in the company and all Group forecasting and strategic planning. Prior to this Stuart was at Shire Pharmaceuticals from 2007 to 2016 where during this time he held the roles of Vice President, Head of Global Audit; Senior Director, Head of Internal Value Management and Senior Director, Head of International Specialty Pharma Finance. In addition, between 2000 and 2007 Stuart worked in a number of finance roles at STERIS including EMEA Finance Director. Stuart has a BSc (Hons) in Physics from Imperial College of Science, Technology & Medicine and is a Chartered Accountant.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --